Investment
Features
FeesSafety
Academy
More
Pluang+

Cantor Fitzgerald raises Bitcoin price assumption to $112K, lifts Strategy share target to $208.

Analyst Insights
17 Oct 2026
Tokenpost
View Source
Bullish
Cantor Fitzgerald raises Bitcoin price assumption to $112K, lifts Strategy share target to $208.

Cantor Fitzgerald increased its 12-month Bitcoin price assumption from $98,000 to $112,000, leading to a higher valuation for Strategy shares. The firm raised its price target for Strategy shares to $208 from $186 and maintained an Overweight rating. Strategy's valuation now reflects an enterprise value of $110 billion, up from $97 billion, based on its holdings of about 848,000 BTC and projected 2027 sales of $509 million. Bitcoin traded around $81,454 on Oct. 17, with Cantor's assumption about 37.5% above the current market price, highlighting confidence in Bitcoin's future value and Strategy's balance sheet strength.

Bitcoin price assumptions by Cantor Fitzgerald provide context for cryptocurrency markets. For readers following crypto, here is Pluang's market snapshot as of Oct 17, 2026 19:21 WIB: out of 50 major cryptocurrencies, 5 rose and 44 fell. ALGO traded at Rp2.013 with a 1-day change of -5.89% and Pluang order activity showing 13% Sell / 87% Buy. AAVE was priced at Rp2.781.125, down 5.32%, with 67% Sell / 33% Buy order activity. COTI stood at Rp201, down 5.04%, with 23% Sell / 77% Buy activity.

More News

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

CHMP gives positive opinion on weekly TransCon CNP for treating achondroplasia in children, EU decision due Q4 2026

Ascendis Pharma announced that the European Medicines Agency's CHMP has given a positive opinion for TransCon CNP (Navepegritid), a once-weekly treatment for achondroplasia in children aged 2 and above with open growth plates. This recommendation sup...

Market News
Bullish
53 minutes ago
EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

EU's CHMP gives positive opinion on weekly TransCon CNP for treating children's achondroplasia

Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...

Market News
Bullish
53 minutes ago
US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

US data centers face a 32-gigawatt power shortfall by 2028, pushing Elon Musk to plan AI operations in space.

Morgan Stanley reports a 32-gigawatt electricity deficit for US data centers through 2028, a 34% shortfall even after alternative power sources. This power gap threatens AI growth as data centers need constant energy to operate. Tech analyst James Al...

Market News
Neutral
1 hour ago
Cisco aims for $200 stock by 2030 amid AI-driven growth and networking super cycle.

Cisco aims for $200 stock by 2030 amid AI-driven growth and networking super cycle.

Cisco's CEO highlights a networking super cycle driving strong revenue growth, with AI orders hitting $9.3B in fiscal 2026. Despite recent stock dips and margin pressures, analysts see potential upside, with a consensus price target of $136.16. To re...

Analyst Insights
Bullish
4 hours ago
Bitcoin's gains could grow with the AI investment bubble, says BitMEX co-founder Arthur Hayes.

Bitcoin's gains could grow with the AI investment bubble, says BitMEX co-founder Arthur Hayes.

Arthur Hayes, co-founder of BitMEX, linked Bitcoin's potential price rise to the size of the artificial intelligence (AI) investment bubble. Speaking on the Convergence program, he noted that major AI companies like OpenAI, Anthropic, and SpaceX are ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App